To elucidate the specific role of PRR in this process, pharmacological agents have been generated, including the Decoy Peptide HPR [29, 30] which inhibits diabetic nephropathy in diabetic rat models [31]. The gene discussed is ATP6AP2; the disease is diabetic kidney disease.